Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.11B
Enterprise Value2.25B
P/E Ratio151.27
PEG Ratio-3.15
Price/Sales Ratio12.13
Price/Book Ratio33.53
Enterprise/Revenue12.82
Enterprise/EBITDA72.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.24

Income Statement

Revenue210.66M
Revenue/Share1.67
Gross Profit82.33M
EBITDA51.08M
Net Income17.62M
Diluted EPS0.14

Balance Sheet

Total Cash44.8M
Total Cash/Share0.37
Total Debt186.43M
Total Debt/Equity2.53
Current Ratio0.84
Book Value Per Share0.8

Price History

52-Week Change30.46
52-Week High23.44
52-Week Low14.37
Moving Average 50 Days18.32
Moving Average 200 Days19

Statistics

Average Volume3.67M
Shares Outstanding121.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.3
Last Split Factor10177:10000
Last Split DateMay 04, 2009
AD